Non-A, non-B hepatitis in chimpanzees and marmosets
- PMID: 6799586
- DOI: 10.1093/infdis/144.6.588
Non-A, non-B hepatitis in chimpanzees and marmosets
Abstract
Nine of 15 specimens of human origin thought to contain non-A, non-B hepatitis agents caused hepatitis in recipient chimpanzees. Two have been further characterized. One inoculum, designated strain F, has been reported to produce unique cytoplasmic changes detected by electron microscopy in liver biopsy specimens; the other, strain H, produced distinctive nuclear changes. It is not yet clear whether these two changes result from infection by different agents; they have been useful markers of non-A, non-B hepatitis in chimpanzees. Strain F was serially passaged six times in chimpanzees, and the infectivity titer of the strain F plasma was estimated to be less than 10(2)/ml. Strain H had an infectivity titer in chimpanzees of at least 10(6)/ml. Both the strain F and strain H agents have been successfully transmitted and serially passaged in marmosets. Although hepatitis was detected in a lower percentage of marmosets than chimpanzees given either the strain F or H inoculum, the infectivity titer of the strain H agent appeared to be greater than or equal to 10(8) marmoset infectious doses/ml.
Similar articles
-
Non-A, non-B hepatitis in experimentally infected chimpanzees with the NIH strains F and H.Acta Pathol Jpn. 1982;32 Suppl 2:315-27. Acta Pathol Jpn. 1982. PMID: 6821268
-
Non-A, non-B hepatitis: is there more than a single blood-borne strain?J Infect Dis. 1985 Apr;151(4):618-25. doi: 10.1093/infdis/151.4.618. J Infect Dis. 1985. PMID: 3919116
-
Transmission of non-A, non-B hepatitis agent to chimpanzees from patients of epidemic hepatitis.Jpn J Med Sci Biol. 1986 Jun;39(3):119-27. doi: 10.7883/yoken1952.39.119. Jpn J Med Sci Biol. 1986. PMID: 3097358
-
Primate animal models and titered inocula for the study of human hepatitis A, hepatitis B, and non-A, non-B hepatitis.J Med Primatol. 1983;12(6):305-18. J Med Primatol. 1983. PMID: 6094814 Review.
-
[Non-A, non-B hepatitis virus: progress achieved].Rev Clin Esp. 1982 Nov 15;167(3):139-41. Rev Clin Esp. 1982. PMID: 6819607 Review. Spanish. No abstract available.
Cited by
-
Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1.Proc Natl Acad Sci U S A. 2005 Mar 22;102(12):4560-5. doi: 10.1073/pnas.0501275102. Epub 2005 Mar 14. Proc Natl Acad Sci U S A. 2005. PMID: 15767578 Free PMC article.
-
Hepatitis C Virus: 30 Years after Its Discovery.Cold Spring Harb Perspect Med. 2019 Dec 2;9(12):a037069. doi: 10.1101/cshperspect.a037069. Cold Spring Harb Perspect Med. 2019. PMID: 31501269 Free PMC article. Review.
-
Hepatitis C virus NS3 serine proteinase: trans-cleavage requirements and processing kinetics.J Virol. 1994 Dec;68(12):8147-57. doi: 10.1128/JVI.68.12.8147-8157.1994. J Virol. 1994. PMID: 7966606 Free PMC article.
-
Genetic variability of hepatitis C virus before and after combined therapy of interferon plus ribavirin.PLoS One. 2008 Aug 26;3(8):e3058. doi: 10.1371/journal.pone.0003058. PLoS One. 2008. PMID: 18725975 Free PMC article.
-
The Rate of Referral of Hepatitis Virus Carriers to Hepatologists and the Factors Contributing to Referral.Intern Med. 2017;56(15):1943-1948. doi: 10.2169/internalmedicine.56.8249. Epub 2017 Aug 1. Intern Med. 2017. PMID: 28768961 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical